Explore strategies for successful clinical trial enrollment in Brazil, focusing on regulatory and recruitment efficiency.
Introduction The evolving regulatory landscape in Brazil presents both challenges and opportunities for MedTech, Biopharma, and Radiopharmaceutical companies. Navigating this landscape can be daunting for many organizations, but it also opens doors to streamline processes and enhance patient recruitment. So, how can sponsors tap into local partnerships, use targeted recruitment strategies, and harness technology to boost enrollment and meet ICH-GCP standards? Let’s dive into the best practices that can reshape Brazil’s clinical trial landscape, positioning organizations for accelerated success in their early-phase studies. Understand Brazil’s Regulatory Landscape for Clinical Trials Navigating Brazil’s regulatory landscape can be daunting for many organizations aiming for clinical trial enrollment in Brazil . Brazil’s regulatory framework for clinical research is primarily overseen by ANVISA (Agência Nacional de Vigilância Sanitária), which manages the approval…